Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TARA

Protara Therapeutics (TARA)

Protara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TARA
DateTimeSourceHeadlineSymbolCompany
07/02/20204:05PMGlobeNewswire Inc.Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TARAProtara Therapeutics Inc
06/11/20201:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/11/20201:41PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TARAProtara Therapeutics Inc
06/11/20201:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/11/20201:38PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TARAProtara Therapeutics Inc
06/11/20201:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/10/20204:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
06/02/20204:05PMGlobeNewswire Inc.Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TARAProtara Therapeutics Inc
05/27/20206:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TARAProtara Therapeutics Inc
05/26/20208:30AMGlobeNewswire Inc.Protara Therapeutics Receives Fast Track Designation from U.S. FDA for Intravenous Choline Chloride for the Treatment of Inte...NASDAQ:TARAProtara Therapeutics Inc
05/14/20205:30PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:TARAProtara Therapeutics Inc
05/13/20208:00AMGlobeNewswire Inc.Protara Therapeutics Announces First Quarter 2020 Financial Results and Business OverviewNASDAQ:TARAProtara Therapeutics Inc
05/13/20206:04AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TARAProtara Therapeutics Inc
05/11/20208:38AMGlobeNewswire Inc.ArTara Therapeutics Announces Corporate Name Change to Protara TherapeuticsNASDAQ:TARAProtara Therapeutics Inc
05/05/20204:05PMGlobeNewswire Inc.ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TARAProtara Therapeutics Inc
04/23/20204:06PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TARAProtara Therapeutics Inc
04/23/20204:04PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TARAProtara Therapeutics Inc
04/09/202010:15AMEdgar (US Regulatory)Other FilingNASDAQ:TARAProtara Therapeutics Inc
04/09/202010:14AMEdgar (US Regulatory)Other FilingNASDAQ:TARAProtara Therapeutics Inc
04/02/20207:00AMGlobeNewswire Inc.ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TARAProtara Therapeutics Inc
03/31/20206:15AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TARAProtara Therapeutics Inc
03/30/20205:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
03/23/20204:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
03/20/20206:05AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:TARAProtara Therapeutics Inc
03/20/20206:03AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:TARAProtara Therapeutics Inc
02/21/202012:28PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TARAProtara Therapeutics Inc
02/18/20204:32PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TARAProtara Therapeutics Inc
02/14/20204:27PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TARAProtara Therapeutics Inc
02/11/20204:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
02/11/20204:17PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TARAProtara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TARA